GUERBET S.A.

Company Introduction: Guerbet S.A. in India

Guerbet S.A. is a global pharmaceutical company specializing in medical imaging. The company develops, manufactures, and commercializes contrast agents, medical devices, and related solutions for diagnostic and interventional procedures, primarily in Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and interventional radiology. Guerbet is known for its commitment to innovation and improving patient outcomes in the field of medical diagnostics.

In India, Guerbet operates through its subsidiary, Guerbet India Private Limited. This entity is responsible for the marketing, sales, and distribution of Guerbet's comprehensive portfolio of contrast media and medical devices across the Indian market. It serves hospitals, diagnostic centers, and healthcare professionals, providing access to Guerbet's advanced imaging solutions.

Regarding its operational nature in India, Guerbet India Private Limited functions as a trading and distribution company. It imports finished products from Guerbet's global manufacturing sites and manages their sales, marketing, and distribution within India. It is not a manufacturing plant or factory in India for the production of contrast agents or medical devices. Its primary role is market penetration, commercial operations, and customer support for the Indian subcontinent.

Therefore, Guerbet S.A. in India is a Trader.

Guerbet S.A. products manufactured or sold in India primarily include a range of contrast media and related medical devices for diagnostic and interventional medical imaging.

Specific product categories include

Contrast Media for Magnetic Resonance Imaging MRI such as gadolinium-based contrast agents.

Contrast Media for Computed Tomography CT and X-ray imaging such as iodine-based contrast agents.

Contrast Media for Interventional Radiology and Cardiology.

Medical Devices for contrast media injection including power injectors and their associated consumables.

Digital Solutions and software for contrast media management and dose tracking.